This study is accepting new patients by invitation only
Long Term Extension Study in Patients With Primary Hyperoxaluria
Summary
- Location
- at UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients by invitation only
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
- ID
- NCT04042402
- Phase
- Phase 3 research study
- Study Type
- Interventional
- Participants
- Expecting 75 study participants
- Last Updated